1,2-dipalmitoyl-3-phosphatidylethanolamine has been researched along with pyrilamine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bogdanovic, RP; Brandes, LJ | 1 |
Brandes, LJ; Kroeger, EA | 1 |
2 other study(ies) available for 1,2-dipalmitoyl-3-phosphatidylethanolamine and pyrilamine
Article | Year |
---|---|
New evidence that the antiestrogen binding site may be a novel growth-promoting histamine receptor (?H3) which mediates the antiestrogenic and antiproliferative effects of tamoxifen.
Topics: Animals; Binding, Competitive; Biological Assay; Cimetidine; Female; Hydroxyzine; Microsomes, Liver; Ovariectomy; Phosphatidylethanolamines; Pyrilamine; Rats; Receptors, Estrogen; Receptors, Histamine; Structure-Activity Relationship; Tamoxifen; Uterus | 1986 |
Evidence that tamoxifen is a histamine antagonist.
Topics: Acetylcholine; Animals; Dogs; Female; Histamine; Histamine Antagonists; Hydroxyzine; Male; Muscle Contraction; Phosphatidylethanolamines; Potassium; Pyrilamine; Serotonin; Tamoxifen; Trachea | 1985 |